"Медицинский институт им.сергея Березина МИБС Первый в России центр протонной терапиии"

During the past decade, St. Petersburg City Oncology Center conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 13 clinical trials were completed, i.e. on average, 65% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Petersburg City Oncology Center" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Biocad" with 4 trials sponsored, "Celgene" with 3 trials sponsored, "Helsinn Healthcare SA" with 2 trials sponsored and "Achieve Life Sciences" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Petersburg City Oncology Center" #1 collaborator was "Eisai Limited" with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator and "PSI CRO" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "St. Petersburg City Oncology Center" are "Breast Cancer" (3 trials), "Crohn Disease" (3 trials), "Breast Neoplasms" (2 trials), "Metastatic Breast Cancer" (2 trials) and "Non-Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "St. Petersburg City Oncology Center" in a lesser frequency.

Most popular intervention types in "St. Petersburg City Oncology Center" are "Drug" (36 trials), "Other" (4 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Atezolizumab" (5 trials), "Carboplatin" (4 trials), "Docetaxel" (3 trials) and "Gemcitabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "St. Petersburg City Oncology Center" are 26 trials for "All" genders, 10 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "St. Petersburg City Oncology Center". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in St. Petersburg City Oncology Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in St. Petersburg City Oncology Center, 3 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".